Indivior Pharmaceuticals, Inc. (INDV)
37.53
+0.07
(+0.19%)
USD |
NASDAQ |
May 22, 16:00
37.55
+0.02
(+0.05%)
After-Hours: 20:00
Indivior Pharmaceuticals Profit Margin (Quarterly) : 28.08% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 11.55% |
| Liquidia Corp. | 39.79% |
| Viatris, Inc. | 5.01% |
| Catalyst Pharmaceuticals, Inc. | 42.66% |
| Theravance Biopharma, Inc. | -27.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 18.89% |
| Return on Invested Capital | 130.6% |
| Gross Profit Margin (Quarterly) | 87.38% |
| Operating Margin (Quarterly) | 46.06% |
| Return on Net Operating Assets | 41.39% |